Investigating the biological and clinical significance of human dysbioses - PubMed (original) (raw)
Investigating the biological and clinical significance of human dysbioses
Daniel N Frank et al. Trends Microbiol. 2011 Sep.
Abstract
Culture-independent microbiological technologies that interrogate complex microbial populations without prior axenic culture, coupled with high-throughput DNA sequencing, have revolutionized the scale, speed and economics of microbial ecological studies. Their application to the medical realm has led to a highly productive merger of clinical, experimental and environmental microbiology. The functional roles played by members of the human microbiota are being actively explored through experimental manipulation of animal model systems and studies of human populations. In concert, these studies have appreciably expanded our understanding of the composition and dynamics of human-associated microbial communities (microbiota). Of note, several human diseases have been linked to alterations in the composition of resident microbial communities, so-called dysbiosis. However, how changes in microbial communities contribute to disease etiology remains poorly defined. Correlation of microbial composition represents integration of only two datasets (phenotype and microbial composition). This article explores strategies for merging the human microbiome data with multiple additional datasets (e.g. host single nucleotide polymorphisms and host gene expression) and for integrating patient-based data with results from experimental animal models to gain deeper understanding of how host-microbe interactions impact disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
Figure 1. Possible etiological significance of dysbiosis
Imbalances in microbial communities might be a necessary condition for disease (A) or an inconsequential result of etiological agents (B) or disease itself (C). Because of the myriad beneficial services provided by the human-associated microbiota, loss of these functions as a result of disease development could further exacerbate the severity, duration, or frequency of disease (D).
Figure 2. Metagenomic tools for studying host-microbiota interactions in human disease
Bacteria are identified through culture independent analysis of 16S rRNA genes amplified from surgical specimens by broad-range PCR. Host genotypes and phenotypes are assessed through analysis of genomic DNA and mRNA of surgical specimens. Together, these data provide insight into how host factors and enteric microbial communities interact during development and/or progression of disease. The ultimate goal of these experiments is to use this knowledge to design, deploy, and monitor novel treatment regimes. Abbreviations: RT, reverse transcription.
Figure 3. Incorporating multimodality microbiome measurements
Schematic diagram of potential determinants of human microbiome and host phenotype (e.g. disease). The central oval (microbiome) depicts an unmeasured latent variable representing the kinds and quantities of microbes that constitute the microbiome. These are inferred by various experimental techniques, including Sanger sequencing, 454 pyrosequencing (using different 16S rRNA primer sets), and quantitative PCR (qPCR). Red arrows denote influences of host and microbiome on host phenotype whereas blue arrows denote causal relationships between host factors and microbiome. The relative contributions of these factors can be modeled using structural equation modeling, as described in the text.
Similar articles
- Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self.
Litvak Y, Bäumler AJ. Litvak Y, et al. Immunity. 2019 Aug 20;51(2):214-224. doi: 10.1016/j.immuni.2019.08.003. Immunity. 2019. PMID: 31433969 Review. - Phylogenetic molecular ecological network of soil microbial communities in response to elevated CO2.
Zhou J, Deng Y, Luo F, He Z, Yang Y. Zhou J, et al. mBio. 2011 Jul 26;2(4):e00122-11. doi: 10.1128/mBio.00122-11. Print 2011. mBio. 2011. PMID: 21791581 Free PMC article. - Meta'omic analytic techniques for studying the intestinal microbiome.
Morgan XC, Huttenhower C. Morgan XC, et al. Gastroenterology. 2014 May;146(6):1437-1448.e1. doi: 10.1053/j.gastro.2014.01.049. Epub 2014 Jan 28. Gastroenterology. 2014. PMID: 24486053 Review. - Gut microbiota, metabolites and host immunity.
Rooks MG, Garrett WS. Rooks MG, et al. Nat Rev Immunol. 2016 May 27;16(6):341-52. doi: 10.1038/nri.2016.42. Nat Rev Immunol. 2016. PMID: 27231050 Free PMC article. Review.
Cited by
- The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review.
Schirò G, Iacono S, Balistreri CR. Schirò G, et al. Neurol Int. 2023 Mar 10;15(1):392-404. doi: 10.3390/neurolint15010026. Neurol Int. 2023. PMID: 36976669 Free PMC article. Review. - Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M, Tsai HC, Fang CY, Hussain B, Chiu YC, Hsu BM. John Kenneth M, et al. J Adv Res. 2023 Oct;52:45-57. doi: 10.1016/j.jare.2022.12.015. Epub 2022 Dec 31. J Adv Res. 2023. PMID: 36596411 Free PMC article. Review. - Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity.
Shaghayegh G, Cooksley C, Ramezanpour M, Wormald PJ, Psaltis AJ, Vreugde S. Shaghayegh G, et al. Biomedicines. 2022 Jun 9;10(6):1362. doi: 10.3390/biomedicines10061362. Biomedicines. 2022. PMID: 35740385 Free PMC article. Review. - Exploring the Gut Microbiome in Myasthenia Gravis.
Thye AY, Law JW, Tan LT, Thurairajasingam S, Chan KG, Letchumanan V, Lee LH. Thye AY, et al. Nutrients. 2022 Apr 14;14(8):1647. doi: 10.3390/nu14081647. Nutrients. 2022. PMID: 35458209 Free PMC article. Review. - The effect of a hydrolyzed protein diet on the fecal microbiota in cats with chronic enteropathy.
Kathrani A, Yen S, Swann JR, Hall EJ. Kathrani A, et al. Sci Rep. 2022 Feb 17;12(1):2746. doi: 10.1038/s41598-022-06576-y. Sci Rep. 2022. PMID: 35177696 Free PMC article.
References
- Flint HJ, et al. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol. 2008;6:121–131. - PubMed
- Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10:159–169. - PubMed
Publication types
MeSH terms
Grants and funding
- R21 HG005964-01/HG/NHGRI NIH HHS/United States
- DK53347/DK/NIDDK NIH HHS/United States
- HG005964/HG/NHGRI NIH HHS/United States
- UH2 DK083994-01/DK/NIDDK NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- R01 HD059527/HD/NICHD NIH HHS/United States
- R01 DK053347/DK/NIDDK NIH HHS/United States
- P40 RR018603-01A1/RR/NCRR NIH HHS/United States
- R21 HG005964/HG/NHGRI NIH HHS/United States
- UH2 DK083994/DK/NIDDK NIH HHS/United States
- RR018603/RR/NCRR NIH HHS/United States
- DK034987/DK/NIDDK NIH HHS/United States
- R01 DK053347-02/DK/NIDDK NIH HHS/United States
- P40 RR018603/RR/NCRR NIH HHS/United States
- HD059527/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources